Your browser doesn't support javascript.
loading
[Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis subsequent to rabbit antithymocyte globulin administration and successfully treated with rituximab in a patient with aplastic anemia].
Nagata, Hiroaki; Fujino, Takahiro; Muramatsu, Ayako; Kawaji, Yuka; Kuriyama, Kodai; Oshiro, Muneo; Hirakawa, Yoshiko; Iwai, Toshiki; Uchiyama, Hitoji.
Afiliação
  • Nagata H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Fujino T; Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine.
  • Muramatsu A; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Kawaji Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Kuriyama K; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Oshiro M; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Hirakawa Y; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Iwai T; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
  • Uchiyama H; Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital.
Rinsho Ketsueki ; 59(4): 407-413, 2018.
Article em Ja | MEDLINE | ID: mdl-29743400

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Vírus Epstein-Barr / Linfo-Histiocitose Hemofagocítica / Rituximab / Soro Antilinfocitário Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged80 / Animals / Humans / Male Idioma: Ja Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por Vírus Epstein-Barr / Linfo-Histiocitose Hemofagocítica / Rituximab / Soro Antilinfocitário Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Aged80 / Animals / Humans / Male Idioma: Ja Ano de publicação: 2018 Tipo de documento: Article